Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125401081 | 12540108 | 1 | I | 20160615 | 20160708 | 20160708 | EXP | US-GLAXOSMITHKLINE-US2016GSK094362 | GLAXOSMITHKLINE | QURESHI M, CATALASAN G. THE USE OF HIGH DOSE INSULIN EUGLYCEMIA THERAPY IN CALCIUM CHANNEL BLOCKER AND BETA BLOCKER OVERDOSE. J- GEN-INTERN MED. 2016;31 (SUPPL) 1-2:S760-S761 | 0.00 | M | Y | 0.00000 | 20160708 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125401081 | 12540108 | 1 | PS | CARVEDILOL PHOSPHATE. | CARVEDILOL PHOSPHATE | 1 | U | 22012 | MODIFIED-RELEASE TABLET | ||||||||||
125401081 | 12540108 | 2 | SS | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | U | 0 | TABLET | ||||||||||
125401081 | 12540108 | 3 | SS | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | U | 0 | |||||||||||
125401081 | 12540108 | 4 | SS | LISINOPRIL. | LISINOPRIL | 1 | U | 0 | |||||||||||
125401081 | 12540108 | 5 | SS | DOXAZOSIN | DOXAZOSINDOXAZOSIN MESYLATE | 1 | U | 0 | |||||||||||
125401081 | 12540108 | 6 | SS | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | U | 0 |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125401081 | 12540108 | OT |
125401081 | 12540108 | DE |
125401081 | 12540108 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125401081 | 12540108 | Acute kidney injury | |
125401081 | 12540108 | Cardiomegaly | |
125401081 | 12540108 | Loss of consciousness | |
125401081 | 12540108 | Overdose | |
125401081 | 12540108 | Pulmonary oedema | |
125401081 | 12540108 | Shock | |
125401081 | 12540108 | Shock haemorrhagic | |
125401081 | 12540108 | Supraventricular tachycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |